Inflammation and intestinal metaplasia at the squamocolumnar junction in young patients with or without Helicobacter pylori infection

Gut

Volumn 52, Issue 2, 2003, Pages 194-198

  Oksanen, A ^a,b,c   Sipponen, P ^d   Karttunen, R ^e   Rautelin, H ^c  

^a Herttoniemi Hospital   (Finland)

^b Herttoniemi Municipal Hospital   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d JORVI HOSPITAL   (Finland)

^e UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ERADICATION THERAPY; FEMALE; GASTRITIS; GASTROINTESTINAL REFLUX; GASTROSCOPY; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; INTESTINE MUCOSA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH BIOPSY;

ADOLESCENT; ADULT; BIOPSY; ESOPHAGITIS; ESOPHAGOGASTRIC JUNCTION; FEMALE; GASTRIC MUCOSA; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METAPLASIA; MIDDLE AGED;

EID: 0037303287     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.2.194     Document Type: Article

References (31)

1. Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998;115:50-7.
2. Weston Ap, Badr AS, Topalovski M, et al. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol 2000;95:387-94.
3. + strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998;58:588-90.
4. Hansen S, Melby KK, Aase S, et al. Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. Scand J Gastroenterol 1999;34:353-60.
5. Blaser MJ. Hypothesis: The changing relationships of Helicobacter pylori and humans: Implications for health and disease. J Infect Dis 1999;179:1523-30.
6. Spechler SJ, Zeroogian JM, Antonioli DA, et al. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994;344:1533-6.
7. Macdonald CE, Wicks AC, Playford RJ. Ten years' experience of screening patients with Barrett's oesophagus in a university teaching hospital. Gut 1997;41:303-7.
8. Hirota WK, Loughney TM, Lazas DJ, et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999;116;277-85.
9. Bytzer P, Christensen PB, Damkier P, et al. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study. Am J Gastroenterol 1999;94:86-91.
10. Conio M, Cameron AJ, Romero Y, et al. Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut 2001;48:304-9.
11. Spechler SJ. The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology 1999;117:218-28.
12. Nandurkar S, Talley NJ, Martin CJ, et al. Short segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut 1997;40:710-15.
13. Johnston MH, Hammond AS, Laskin W, et al. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Am J Gastroenterol 1996;91:1507-11.
14. Trudgill NJ, Suvarna SK, Kapur KC, et al. Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy. Gut 1997;41:585-9.
15. Goldblum JR, Vicari JJ, Falk GW, et al. Inflammation and intestinal metaplasia of the gastric cardia: The role of gastroesophageal reflux and H. pylori infection. Gastroenterology 1998;114:633-9.
16. Ormsby AH, Kilgore SP, Goldblum JR, et al. The location and frequency of intestinal metaplasia at the esophagogastric junction in 223 consecutive autopsies: Implications for patient treatment and preventive strategies in Barrett's esophagus. Mod Pathol 2000;13:614-20.
17. Oksanen A, Sipponen P, Sarna S, Rautelin H. Serologic diagnosis of Helicobacter pylori infection in outpatients aged 45 years or less. Eur J Mirobiol Infect Dis 2001;20:554-7.
18. Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of oesophagitis: a progress report on observer agreement. Gastroenterology 1966;111:85-92.
19. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney system. Am J Surg Pathol 1996;20:1161-81.
20. Bowrey DJ, Clark GWB, Williams GT. Patterns of gastritis in patients with gastro-oesophageal reflux disease. Gut 1999;45:798-803.
21. Voutilainen M, Färkkilä M, Mecklin J-P, et al. Chronic inflammation at the gastroesophageal junction (carditis) appears to be a specific finding related to Helicobacter pylori and gastroesophageal reflux disease. Am J Gastroenterol 1999;94:3175-80.
22. Wieczorek TJ, Wang HH, Glickman J, et al. Clinical-pathologic distinction between reflux carditis and H. pylori carditis. Mod Pathol 2002;15:148A.
23. Chandrasoma PT, Lokuhetty DM, Demeester TR, et al. Definition of histopathologic changes in gastroesophageal reflux disease. Am J Surg Pathol 2000;24:344-51.
24. Chandrasoma PT, Der R, Ma Y, et al. Histology of the gastroesophageal junction. An autopsy study. Am J Surg Pathol 2000;24:402-29.
25. Kilgore SP, Ormsby AH, Gramlich TL, et al. The gastric cardia: fact or fiction? Am J Gastroenterol 2000;95:921-4.
26. Öberg S, Peters JH, DeMeester TR, et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 1997;226;522-32.
27. Hackelsberger A, Gunther T, Schultze V, et al. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis ar gastro-oesophageal reflux disease? Gut 1998;43:17-21.
28. Filipe MI, Potet F, Bogomoletz WV, et al. Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres. Gut 1985;26:1319-26.
29. Voutilainen M, Färkkilä M, Juhola M, et al. Complete and incomplete intestinal metaplasia at the oesophagogastric junction: prevalences and associations with endoscopic erosive oesophagitis and gastritis. Gut 1999;45:644-8.
30. Aste H, Bonelli L, Ferraris R, et al. Gastroesophageal reflux disease. Relationship between clinical and histological features. Dig Dis Sci 1999;44:2412-18.
31. Eloubeidi MA, Provenzale D. Does this patient have Barrett's esophagus? The utility of predicting Barrett's esophagus at the index endoscopy. Am J Gastroenterol 1999;94:937-43.